Silodosin Capsule
Product Images NDC 33342-385

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 33342-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30s (Silodosin 4 mg 30s)

30s (Silodosin 4 mg 30s)
Pharmma USA's Silodosin Capsules in 4mg dosage comes in a pack of 30. They should be orally consumed with a meal once a day. The package insert contains complete prescribing information. The medicine should be stored between 20° to 25°C (68° to 77°F) with excursions authorized between 15° to 30°C(59° to 86° F). The medicine shall be kept away from light and moisture and out of reach of children. The manufacturer is Macleods Pharma USA, Inc. based in Princeton, NJ, and the manufacturer's location is Daman (U.T), INDIA, Macleods Pharmaceuticals Ltd. Code No.: DD/DRUGS/DD/375, PM02906602.*
FDA Label Image

Silodosin 4 mg 90s

Silodosin 4 mg 90s
This is a medication containing Silodosin 4mg in a capsule form. It is to be taken orally once daily with food. It should be stored at room temperature between 68-77F and kept away from children. The medication is manufactured by Macleods Pharma and comes in a bottle of 90 capsules. Full prescribing information is available.*
FDA Label Image

30s (Silodosin 8 mg 30s)

30s (Silodosin 8 mg 30s)
The text describes a medication called "Lodosin Capsules" with Silodosin 8mg as the active ingredient. It contains 30 capsules that are meant to be taken orally once a day with a meal. The package insert provides the complete prescribing information. It also includes instructions for storage and mentions the manufacturer details.*
FDA Label Image

90s (Silodosin 8 mg 90s)

90s (Silodosin 8 mg 90s)
This is a drug description for Silodosin capsules containing 8 mg of the drug per capsule. The recommended dosage is 1 capsule taken orally once daily with a meal. The capsules should be stored at a temperature between 20°C-25°C (68°F to 77°F), with excursions permitted between 15°C-30°C (59°F to 86°F). The drug should be kept out of reach of children and protected from light and moisture. The manufacturing information is also provided.*
FDA Label Image

123 (Silodosin Cart 4mg)

123 (Silodosin Cart 4mg)
This is a prescription drug package for Silodosin Capsules, 4mg used for treating the symptoms of benign prostatic hyperplasia. It contains 100 capsules organized into 10 unit-dose containers. The package has been manufactured by Macleods Pharma USA and Macleods Pharmaceuticals Ltd. The usual dosage for this drug is 1 capsule orally once daily with a meal. This package is not child-resistant and should be stored at temperatures between 20°C to 25°C. For more information, users should refer to the package insert.*
FDA Label Image

444 (Silodosin Cart 8mg)

444 (Silodosin Cart 8mg)
This is a description of a medication called Silodosin Capsules manufactured by Macleods Pharma USA. The medication comes in a bottle of 100 capsules and each capsule contains Silodosin 8mg. The package insert must be reviewed for full prescribing information. It is recommended to store the medication between 20° to 25°C (68° to 77°F) with excursions permited between 15° 10 30°C(59° to 86° F), protected from light and moisture. The product should be kept out of reach of children. The package is not child-resistant. Batch No. and Code No. are also given.*
FDA Label Image

333 (Silodosin Fig 02)

FDA Label Image

222 (Silodosin Fig 1)

FDA Label Image

444 (Silodosin Fig 3)

FDA Label Image

555 (Silodosin Fig 5)

FDA Label Image

Silodosin Figure 4

FDA Label Image

111 (Silodosin Str 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.